Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions

Madeleine J Bunders1, Marcus Altfeld2

  • 1Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.

Immunity
|August 28, 2020
PubMed

Insights

Men experience more severe coronavirus disease 2019 (COVID-19) and higher mortality risk. Understanding sex-based immune differences in SARS-CoV-2 infection is crucial for developing targeted COVID-19 therapies.

Area of Science:

  • Immunology
  • Virology
  • Sex Differences in Health

Background:

  • Men exhibit higher severity and mortality rates for COVID-19 compared to women.
  • The biological mechanisms driving these sex-based disparities in SARS-CoV-2 infection remain unclear.
  • Prior research indicates females may possess more robust immune responses to viral infections.

Purpose of the Study:

  • To investigate the underlying mechanisms of sex differences in COVID-19 severity and outcomes.
  • To explore how sex-based immune response variations influence SARS-CoV-2 pathogenesis.
  • To identify potential therapeutic targets for enhancing antiviral immunity and mitigating inflammation in COVID-19.

Main Methods:

  • This study synthesizes existing research on sex differences in immune responses to viral infections.
  • It reviews current knowledge on SARS-CoV-2 pathogenesis and pathology.
  • Focuses on biological pathways underlying immune variations between sexes.

Main Results:

  • Emerging evidence suggests females mount stronger antiviral immune responses.
  • Differences in immune pathways between males and females are critical to SARS-CoV-2.
  • These disparities impact disease severity and outcomes.

Conclusions:

  • Integrating knowledge of sex-based immune differences into COVID-19 research is essential.
  • Identifying these pathways can lead to novel therapeutic strategies.
  • Interventions could enhance antiviral immunity, improve lung resilience, and reduce harmful inflammation in COVID-19 patients.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
753
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.7K